Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ TASP1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA556567
Description
Immunogen sequence: ENDSGTLDTV GAVVVDHEGN VAAAVSSGGL ALKHPGRVGQ AALYGCGCWA ENTGAHNPYS TAVSTSGCGE HLVRTILARE CSHALQAEDA HQAL Highest antigen sequence identity to the following orthologs: Mouse - 99%, Rat - 99%.
This gene encodes an endopeptidase that cleaves specific substrates following aspartate residues. The encoded protein undergoes posttranslational autoproteolytic processing to generate alpha and beta subunits, which reassemble into the active alpha2-beta2 heterotetramer. It is required to cleave MLL, a protein required for the maintenance of HOX gene expression, and TFIIA, a basal transcription factor. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.
Specifications
TASP1 | |
Polyclonal | |
Unconjugated | |
TASP1 | |
4930485D02Rik; AW986064; C20orf13; dJ585I14.2; FLJ20212; MGC39159; RGD1308591; si:dkey-38k3.3; Tasp1; taspase 1; taspase, threonine aspartase 1; taspase, threonine aspartase, 1; taspase-1; Threonine aspartase 1; Threonine aspartase 1-like protein; Threonine aspartase subunit alpha; Threonine aspartase subunit beta | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
55617 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.05 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q9H6P5 | |
TASP1 | |
Recombinant protein corresponding to Human TASP1. Recombinant protein control fragment (Product #RP-95821). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction